Chou H C, Ozawa S, Fu P P, Lang N P, Kadlubar F F
National Center for Toxicological Research (HFT-100), Jefferson, AR 72079, USA.
Carcinogenesis. 1998 Jun;19(6):1071-6. doi: 10.1093/carcin/19.6.1071.
Methyl-hydroxylated metabolites of the potent carcinogen, 7,12-dimethylbenz[a]anthracene (DMBA), namely, 7-hydroxymethyl-12-methylbenz[a]anthracene (7-OH-DMBA), 7-methyl-12-hydroxymethylbenz[a]anthracene (12-OH-DMBA) and 7,12-dihydroxymethylbenz[a]anthracene (7,12-diOH-DMBA), were examined as substrates for sulfotransferase bioactivation in different human tissue cytosols. Hepatic cytosols, which were able to catalyze the 3'-phosphoadenosine 5'-phosphosulfate (PAPS)-dependent DNA binding of 7-OH-DMBA, 12-OH-DMBA and 7,12-diOH-DMBA, were highly sensitive to inhibition by dehydroepiandrosterone (DHEA), a specific substrate for human DHEA-steroid sulfotransferase (IC50 = 5 microM). By comparison, 2,6-dichloro-4-nitrophenol, a potent inhibitor of the thermostable (TS)-phenol and estrogen sulfotransferases, did not have an appreciable inhibitory effect. Neither p-nitrophenol, a high affinity substrate for human TS-phenol and estrogen sulfotransferases, nor dopamine, a specific substrate for the thermolabile (TL)-phenol sulfotransferase, significantly inhibited the DNA binding of 12-OH-DMBA catalyzed by hepatic cytosols. Inter-subject variation (n = 12) of the PAPS-dependent DNA binding of 12-OH- and 7,12-diOH-DMBAs also correlated well with DHEA-sulfotransferase activity (r = 0.90; P < 0.00001 and r = 0.92; P < 0.00001, respectively). This sulfation-dependent metabolic activation was not detected in cytosols from human colon, pancreas, larynx or mammary gland. Both TS- and TL-phenol sulfotransferases were active in human liver and colon but only liver contained DHEA-sulfotransferase activity. These results indicate that the sulfotransferase-mediated activation of the methyl-hydroxylated DMBAs is predominantly catalyzed by DHEA-steroid sulfotransferase in human liver and that TS- and TL-phenol sulfotransferases and estrogen sulfotransferase are not involved in the catalysis.
强效致癌物7,12 - 二甲基苯并[a]蒽(DMBA)的甲基羟基化代谢产物,即7 - 羟甲基 - 12 - 甲基苯并[a]蒽(7 - OH - DMBA)、7 - 甲基 - 12 - 羟甲基苯并[a]蒽(12 - OH - DMBA)和7,12 - 二羟甲基苯并[a]蒽(7,12 - 二OH - DMBA),被作为不同人体组织胞质溶胶中磺基转移酶生物活化的底物进行研究。能够催化7 - OH - DMBA、12 - OH - DMBA和7,12 - 二OH - DMBA的3'-磷酸腺苷5'-磷酸硫酸酯(PAPS)依赖性DNA结合的肝细胞质溶胶,对脱氢表雄酮(DHEA)高度敏感,DHEA是人类DHEA - 类固醇磺基转移酶的特异性底物(IC50 = 5 microM)。相比之下,2,6 - 二氯 - 4 - 硝基苯酚,一种热稳定(TS) - 苯酚和雌激素磺基转移酶的强效抑制剂,没有明显的抑制作用。对人类TS - 苯酚和雌激素磺基转移酶具有高亲和力的底物对硝基苯酚,以及热不稳定(TL) - 苯酚磺基转移酶的特异性底物多巴胺,均未显著抑制肝细胞质溶胶催化的12 - OH - DMBA的DNA结合。12 - OH - DMBA和7,12 - 二OH - DMBA的PAPS依赖性DNA结合的个体间差异(n = 12)也与DHEA - 磺基转移酶活性高度相关(分别为r = 0.90;P < 0.00001和r = 0.92;P < 0.00001)。在人结肠、胰腺、喉或乳腺的胞质溶胶中未检测到这种硫酸化依赖性代谢活化。TS - 和TL - 苯酚磺基转移酶在人肝脏和结肠中均有活性,但只有肝脏含有DHEA - 磺基转移酶活性。这些结果表明,甲基羟基化DMBA的磺基转移酶介导的活化主要由人肝脏中的DHEA - 类固醇磺基转移酶催化,而TS - 和TL - 苯酚磺基转移酶以及雌激素磺基转移酶不参与催化。